Clincosm LogoSign in Get a demo

Validation of a Nutrition Screening Tool

Sponsor
Royal Marsden NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT01851928
Collaborator
(none)
128
Enrollment
1
Location
20
Duration (Months)
6.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate the sensitivity and specificity of two nutrition screening tools to identify inpatients with malnutrition or at risk of malnutrition. The two tools are the Royal Marsden Abridged Adult Nutrition Screening Tool (AANST) and the Malnutrition Screening Tool (MST)[10] The tools will be compared with the currently accepted gold standard, Patient Generated Subjective Global Assessment (PG-SGA). Both screening tools are in the form of scored questionnaires and are suitable for electronic input.

The ultimate objective is to select an adult inpatient nutrition screening tool with the highest sensitivity for future use in the oncology inpatient setting in order to allow prompt commencement of an appropriate nutrition care plan.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    128 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Validation of Two Inpatient Adult Nutrition Screening Tools in Cancer Care - a Prospective Study
    Study Start Date :
    Jul 1, 2011
    Actual Primary Completion Date :
    Sep 1, 2012
    Actual Study Completion Date :
    Mar 1, 2013

    Outcome Measures

    Primary Outcome Measures

    1. Sensitivity of Screening Tool [24 hrs]

      The primary endpoint of the study is the sensitivity of each screening tool as compared to the gold standard of PG-SGA when completed by a trained dietitian.

    Secondary Outcome Measures

    1. Specificity of the Tool [24 hrs]

      Secondary endpoints are as follows: specificity of the screening tool proportion of inpatients with malnutrition on admission

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All adult inpatients, over the age of 18, admitted to RMH for whom a measured weight and height can be obtained

    Exclusion Criteria

    • Patients for whom it is not possible to obtain a measured height and weight

    • People with a definitive diagnosis of dementia

    • People who lack capacity to understand the purpose of the study and to consent

    • Patients who are unable to understand and speak English

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Royal Marsden Hospital NHS Foundation Trust London London .. United Kingdom SW3 6JJ

    Sponsors and Collaborators

    • Royal Marsden NHS Foundation Trust

    Investigators

    • Principal Investigator: Clare Shaw, Phd, Royal Marsden Hospital NHS Foundation Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Royal Marsden NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT01851928
    Other Study ID Numbers:
    • CCR 3621
    First Posted:
    May 13, 2013
    Last Update Posted:
    May 13, 2013
    Last Verified:
    May 1, 2013
    Additional relevant MeSH terms:
    Endometrial Neoplasms
    Fallopian Tube Neoplasms
    Vulvar Neoplasms
    Vaginal Neoplasms

    Study Results

    No Results Posted as of May 13, 2013